TBPH logo

Theravance Biopharma (TBPH) Short Term Debt

Annual Short Term Debt

$3.92 M
-$2.83 M-41.91%

December 31, 2023


Summary


Performance

TBPH Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTBPHbalance sheetmetrics:

Quarterly Short Term Debt

$4.20 M
-$23.00 K-0.55%

September 30, 2024


Summary


Performance

TBPH Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTBPHbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

TBPH Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.9%-56.8%
3 y3 years-86.6%-69.0%
5 y5 years+100.0%-85.6%

TBPH Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-77.5%at low-75.9%+506.4%
5 y5-year-86.6%at low-85.6%+506.4%
alltimeall time-86.6%-100.0%-85.6%-100.0%

Theravance Biopharma Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$4.20 M(-0.5%)
Jun 2024
-
$4.22 M(+3.8%)
Mar 2024
-
$4.06 M(+3.6%)
Dec 2023
$3.92 M(-41.9%)
$3.92 M(-59.6%)
Sep 2023
-
$9.71 M(+6.0%)
Jun 2023
-
$9.16 M(+23.3%)
Mar 2023
-
$7.43 M(+10.0%)
Dec 2022
$6.75 M(-61.3%)
$6.75 M(+875.9%)
Sep 2022
-
$692.00 K(-73.6%)
Jun 2022
-
$2.62 M(-79.9%)
Mar 2022
-
$13.07 M(-25.1%)
Dec 2021
$17.44 M
$17.44 M(+28.8%)
DateAnnualQuarterly
Sep 2021
-
$13.55 M(+69.8%)
Jun 2021
-
$7.98 M(-38.1%)
Mar 2021
-
$12.88 M(-55.9%)
Dec 2020
$29.20 M(+65.8%)
$29.20 M(+201.5%)
Sep 2020
-
$9.69 M(+10.8%)
Jun 2020
-
$8.74 M(+9.9%)
Mar 2020
-
$7.95 M(-54.8%)
Dec 2019
$17.61 M(>+9900.0%)
$17.61 M(+13.4%)
Sep 2019
-
$15.53 M(-23.2%)
Jun 2019
-
$20.23 M(+143.8%)
Mar 2019
-
$8.30 M(>+9900.0%)
Dec 2018
$0.00
$0.00

FAQ

  • What is Theravance Biopharma annual short term debt?
  • What is the all time high annual short term debt for Theravance Biopharma?
  • What is Theravance Biopharma annual short term debt year-on-year change?
  • What is Theravance Biopharma quarterly short term debt?
  • What is the all time high quarterly short term debt for Theravance Biopharma?
  • What is Theravance Biopharma quarterly short term debt year-on-year change?

What is Theravance Biopharma annual short term debt?

The current annual short term debt of TBPH is $3.92 M

What is the all time high annual short term debt for Theravance Biopharma?

Theravance Biopharma all-time high annual short term debt is $29.20 M

What is Theravance Biopharma annual short term debt year-on-year change?

Over the past year, TBPH annual short term debt has changed by -$2.83 M (-41.91%)

What is Theravance Biopharma quarterly short term debt?

The current quarterly short term debt of TBPH is $4.20 M

What is the all time high quarterly short term debt for Theravance Biopharma?

Theravance Biopharma all-time high quarterly short term debt is $29.20 M

What is Theravance Biopharma quarterly short term debt year-on-year change?

Over the past year, TBPH quarterly short term debt has changed by -$5.52 M (-56.80%)